These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 412213)

  • 1. Perlapine: relationship between stimulation of prolactin secretion and antipsychotic activity.
    Meltzer HY; Fessler RG; Fang VS
    Psychopharmacology (Berl); 1977 Oct; 54(2):183-6. PubMed ID: 412213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of clozapine on dopamine-induced inhibition of prolactin release from cultured rat pituitary cells.
    Braghiroli L; Ponzianelli A; Fiani M; De Feo G; Cheng CY; Mazzanti G
    Pharmacol Res; 1997 Mar; 35(3):173-5. PubMed ID: 9229404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic drugs stimulate prolactin release.
    Clemens JA; Smalstig EB; Sawyer BD
    Psychopharmacologia; 1974; 40(2):123-7. PubMed ID: 4155803
    [No Abstract]   [Full Text] [Related]  

  • 4. Perlapine and dopamine metabolism: prediction of antipsychotic efficacy.
    Wilk S; Stanley M
    Eur J Pharmacol; 1977 Jan; 41(1):65-72. PubMed ID: 12986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pirenperone and ketanserin on rat prolactin secretion in vivo and in vitro.
    Meltzer HY; Simonovic M; Gudelsky GA
    Eur J Pharmacol; 1983 Aug; 92(1-2):83-9. PubMed ID: 6628538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradoxical effect of neuroleptic drugs on prolactin secretion by rat pituitary cell cultures.
    Braghiroli L; Ponzianelli A; Mazzanti G
    Life Sci; 1999; 65(14):1455-61. PubMed ID: 10530797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of clozapine and other dibenzo-epines on central dopaminergic and cholinergic systems. Structure-activity relationships.
    Bürki HR; Sayers AC; Ruch W; Asper H
    Arzneimittelforschung; 1977; 27(8):1561-5. PubMed ID: 20900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prolactin response in clinical psychiatry.
    Gruen PH
    Med Clin North Am; 1978 Mar; 62(2):409-24. PubMed ID: 347199
    [No Abstract]   [Full Text] [Related]  

  • 9. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
    Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine receptors involved in prolactin secretion pharmacologically characterized by means of 3-PPP enantiomers.
    Eriksson E; Modigh K; Carlsson A; Wikström H
    Eur J Pharmacol; 1983 Dec; 96(1-2):29-36. PubMed ID: 6662196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin and neuroleptics: clinical implications for efficacy and toxicity. The effect of neuroleptics and alpha-methyl-para-tyrosine on serum prolactin levels in laboratory animals and man.
    Meltzer HY; Fang VS; Goode DJ
    Psychopharmacol Bull; 1978 Jan; 14(1):5-7. PubMed ID: 625539
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolactin responses to neuroleptics in normal and schizophrenic subjects.
    Gruen PH; Sachar EJ; Langer G; Altman N; Leifer M; Frantz A; Halpern FS
    Arch Gen Psychiatry; 1978 Jan; 35(1):108-16. PubMed ID: 23087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supersensitivity of pituitary dopamine receptors involved in the inhibition of prolactin secretion.
    Annunziato L; Quattrone A; Schettini G; Di Renzo G
    Adv Biochem Psychopharmacol; 1980; 24():379-85. PubMed ID: 6105788
    [No Abstract]   [Full Text] [Related]  

  • 14. Adenylate cyclase from various dopaminergic areas of the brain and the action of loxapine.
    Clement-Cormier YC
    Adv Exp Med Biol; 1977; 90():183-90. PubMed ID: 930743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of benztropine on haloperidol-induced prolactin secretion.
    Lal S; Mendis T; Cervantes P; Guyda H; DeRivera JL
    Neuropsychobiology; 1979; 5(6):327-31. PubMed ID: 503307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal effects of JL 13, a pyridobenzoxazepine derivative with an antipsychotic potential, on circulating prolactin levels in male rats.
    Liégeois JF; Bruhwyler J; Hendrick JC; Delarge J; Legros JJ; Damas J
    Neurosci Lett; 2002 Feb; 319(1):49-52. PubMed ID: 11814651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thioridazine stimulates prolactin secretion in man.
    Sachar EJ; Gruen PH; Karasu TB; Altman N; Frantz AG
    Arch Gen Psychiatry; 1975 Jul; 32(7):885-6. PubMed ID: 239662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysergic acid diethylamide: evidence for stimulation of pituitary dopamine receptors.
    Meltzer HY; Fessler RG; Simonovic M; Doherty J; Fang VS
    Psychopharmacology (Berl); 1977 Aug; 54(1):39-44. PubMed ID: 143671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of SCH 23390, a D-1-selective antagonist, with the anterior pituitary D-2 receptors and prolactin secretion in the rat.
    Apud JA; Masotto C; Ongini E; Racagni G
    Eur J Pharmacol; 1985 Jun; 112(2):187-93. PubMed ID: 2863153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin levels and amphetamine-induced behavioural changes following fluphenazine decanoate administration.
    Merali Z
    Prog Neuropsychopharmacol; 1981; 5(5-6):603-7. PubMed ID: 7339653
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.